Reproducible Community Dynamics of the Gastrointestinal Microbiota following Antibiotic Perturbation
暂无分享,去创建一个
Hilary G. Morrison | Susan M. Huse | Mitchell L. Sogin | Dionysios A. Antonopoulos | Vincent B. Young | M. Sogin | H. Morrison | D. Antonopoulos | S. Huse | T. Schmidt | V. Young | Thomas M. Schmidt | T. Schmidt
[1] Susan M. Huse,et al. Exploring Microbial Diversity and Taxonomy Using SSU rRNA Hypervariable Tag Sequencing , 2008, PLoS genetics.
[2] D. Broide. Allergic Disease , 2020, Berkowitz’s Pediatrics Instructor’s Guide.
[3] Thomas D. Schmittgen,et al. Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.
[4] J. Bartlett,et al. Historical perspectives on studies of Clostridium difficile and C. difficile infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[5] E. Vollaard,et al. Colonization resistance , 1994, Antimicrobial Agents and Chemotherapy.
[6] E. Zoetendal,et al. Temperature Gradient Gel Electrophoresis Analysis of 16S rRNA from Human Fecal Samples Reveals Stable and Host-Specific Communities of Active Bacteria , 1998, Applied and Environmental Microbiology.
[7] J. Bakken,et al. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] S. Conway,et al. Bacterial modulation of mucosal innate immunity. , 2005, Molecular immunology.
[9] Robert C. Edgar,et al. MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.
[10] K. Madsen,et al. Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. , 2000, Gastroenterology.
[11] A. Solow,et al. Measuring biological diversity , 2006, Environmental and Ecological Statistics.
[12] K. Wilson,et al. Human colonic biota studied by ribosomal DNA sequence analysis , 1996, Applied and environmental microbiology.
[13] M. Membrez,et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[14] K. Wilson. The microecology of Clostridium difficile. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] Susan M. Huse,et al. Accuracy and quality of massively parallel DNA pyrosequencing , 2007, Genome Biology.
[16] S. Allison,et al. Resistance, resilience, and redundancy in microbial communities , 2008, Proceedings of the National Academy of Sciences.
[17] Jeffrey D Goldsmith,et al. A mouse model of Clostridium difficile-associated disease. , 2008, Gastroenterology.
[18] T Midtvedt,et al. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[19] W. Moore,et al. Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress , 1976, Applied and environmental microbiology.
[20] F. Shanahan,et al. Culture-Independent Analyses of Temporal Variation of the Dominant Fecal Microbiota and Targeted Bacterial Subgroups in Crohn's Disease , 2006, Journal of Clinical Microbiology.
[21] G. Huffnagle,et al. The ‘microflora hypothesis’ of allergic diseases , 2005, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[22] Courtney J. Robinson,et al. Rules of engagement: interspecies interactions that regulate microbial communities. , 2008, Annual review of microbiology.
[23] N. Pace,et al. Gastrointestinal microbiology enters the metagenomics era , 2008, Current opinion in gastroenterology.
[24] Ruslan Medzhitov,et al. Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.
[25] D. Savage. Microbial ecology of the gastrointestinal tract. , 1977, Annual review of microbiology.
[26] R. Flavell,et al. An Antibiotic-Responsive Mouse Model of Fulminant Ulcerative Colitis , 2008, PLoS medicine.
[27] Ronald P. DeMatteo,et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits , 2008, Nature.
[28] W. Walker. Mechanisms of action of probiotics. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[29] Robert K. Colwell,et al. Quantifying biodiversity: procedures and pitfalls in the measurement and comparison of species richness , 2001 .
[30] P. Sansonetti,et al. Debugging how bacteria manipulate the immune response. , 2007, Immunity.
[31] A. Chao. Nonparametric estimation of the number of classes in a population , 1984 .
[32] P. Turnbaugh,et al. Microbial ecology: Human gut microbes associated with obesity , 2006, Nature.
[33] J. Gordon,et al. A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[34] R. Freter,et al. In vivo and in vitro antagonism of intestinal bacteria against Shigella flexneri. I. Correlation between various tests. , 1962, The Journal of infectious diseases.
[35] R. Ley,et al. Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine , 2006, Cell.
[36] K. Verbeke,et al. Molecular Monitoring of the Fecal Microbiota of Healthy Human Subjects during Administration of Lactulose and Saccharomyces boulardii , 2006, Applied and Environmental Microbiology.
[37] E. Mylonakis,et al. Clostridium difficile--Associated diarrhea: A review. , 2001, Archives of internal medicine.
[38] E. Mardis,et al. An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.
[39] R. Freter. In vivo and in vitro antagonism of intestinal bacteria against Shigellaflexneri. II. The inhibitory mechanism. , 1962, The Journal of infectious diseases.
[40] N. Pace,et al. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. , 2008, Cell host & microbe.
[41] R. Knight,et al. Evolution of Mammals and Their Gut Microbes , 2008, Science.
[42] R Balfour Sartor,et al. Microbial influences in inflammatory bowel diseases. , 2008, Gastroenterology.
[43] J. Handelsman,et al. Introducing DOTUR, a Computer Program for Defining Operational Taxonomic Units and Estimating Species Richness , 2005, Applied and Environmental Microbiology.
[44] R. Satokari,et al. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. , 2006, Journal of medical microbiology.
[45] E. Purdom,et al. Diversity of the Human Intestinal Microbial Flora , 2005, Science.
[46] Neil Hunter,et al. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. , 2002, Microbiology.
[47] S. Maroo,et al. Recurrent clostridium difficile. , 2006, Gastroenterology.
[48] D. Relman,et al. Assembly of the human intestinal microbiota. , 2006, Trends in ecology & evolution.
[49] J. Rask-Madsen,et al. BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTS , 1989, The Lancet.
[50] B. Finlay,et al. Antibiotic-Induced Perturbations of the Intestinal Microbiota Alter Host Susceptibility to Enteric Infection , 2008, Infection and Immunity.
[51] L. Beaugerie,et al. Effect of Antibiotic Therapy on Human Fecal Microbiota and the Relation to the Development of Clostridium difficile , 2008, Microbial Ecology.
[52] J. Jansson,et al. Clindamycin-induced enrichment and long-term persistence of resistant Bacteroides spp. and resistance genes. , 2006, The Journal of antimicrobial chemotherapy.
[53] Susan M. Huse,et al. Microbial diversity in the deep sea and the underexplored “rare biosphere” , 2006, Proceedings of the National Academy of Sciences.
[54] W. Walker,et al. Probiotics and chronic disease. , 2006, Journal of clinical gastroenterology.
[55] N. Pace. A molecular view of microbial diversity and the biosphere. , 1997, Science.
[56] R Balfour Sartor,et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. , 2008, Cell host & microbe.
[57] F. Bäckhed,et al. Host-Bacterial Mutualism in the Human Intestine , 2005, Science.
[58] Les Dethlefsen,et al. The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing , 2008, PLoS biology.
[59] G. Huffnagle,et al. The "Microflora Hypothesis" of allergic disease. , 2008, Advances in experimental medicine and biology.
[60] Susan M. Huse,et al. Microbial Population Structures in the Deep Marine Biosphere , 2007, Science.
[61] A. Magurran,et al. Measuring Biological Diversity , 2004 .
[62] W. Siegert,et al. Quantification of human cells in NOD/SCID mice by duplex real-time polymerase-chain reaction. , 2001, Haematologica.
[63] D. Antonopoulos,et al. Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. , 2008, The Journal of infectious diseases.
[64] M. Sanders. Probiotics: definition, sources, selection, and uses. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.